Loading
Sentiment · FY2027 Q1
As of FY2026 Q4, the Tellvest earnings-call sentiment score for Steris (STE) is 7/10.
STERIS delivered a record fiscal year with $6 billion in revenue and $1 billion in net income, introducing FY2027 guidance of $11.10-$11.30 EPS implying 9-11% growth on 6-7% organic revenue expansion. Q4 revenue grew 7% with adjusted EPS up 3% to $2.83 as tariff headwinds pressured margins by 80 basis points and AST softened from weather and MedTech inventory pullbacks. Free cash flow reached an exceptional $982.9 million while strategic manufacturing and AI investments were positioned to drive FY2027 acceleration.
Scored from Steris’s FY2026 Q4 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q2 | $1.33B | +7.3% | $1.51 | +30.2% | 43.6% | 16.5% | 11.3% | $149M |
| FY2025 Q3 | $1.37B | +5.6% | $1.75 | +23.2% | 44.5% | 17.9% | 12.7% | $244M |
| FY2025 Q4 | $1.48B | +4.0% | $1.48 | +10747.5% | 43.3% | 14.6% | 9.8% | $190M |
| FY2026 Q1 | $1.39B | +8.7% | $1.79 | +22.6% | 45.1% | 17.7% | 12.8% | $326M |
| FY2026 Q2 | $1.46B | +9.9% | $1.94 | +28.5% | 44.2% | 18.4% | 13.1% | $201M |
| FY2026 Q3 | $1.50B | +9.2% | $1.96 | +12.0% | 43.8% | 18.1% | 12.9% | $200M |
| FY2026 Q4 | $1.59B | +7.3% | $2.24 | +51.4% | 43.9% | 19.9% | 13.9% | $245M |
| FY2027 Q1 | $1.49B | +7.3% | $2.04 | +14.0% | 45.8% | 19.1% | 13.4% | $280M |